Observational Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Dec 26, 2024; 12(36): 6916-6925
Published online Dec 26, 2024. doi: 10.12998/wjcc.v12.i36.6916
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Demographic parameters of the participants. A: Healthy controls, obese and obese with type 2 diabetes mellitus participants; B: Male and female participants in the healthy controls, obese and obese with type 2 diabetes mellitus; C: Hypertensive and non-hypertensive participants in the healthy controls, obese and obese with type 2 diabetes mellitus; D: Smoking and nonsmoking participants in the healthy controls, obese and obese with type 2 diabetes mellitus. T2DM: Type 2 diabetes mellitus.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 MiRNA-200a and miRNA-200b expression. A: Obese; B: Obese with type 2 diabetes mellitus. T2DM: Type 2 diabetes mellitus.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Comparison of miRNA-200a and miRNA-200b expression with regard to hypertension and smoking in obese and obese with type 2 diabetes mellitus participants. A: MiRNA-200a; B: MiRNA-200b.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Level of vitamin D in obese and obese with type 2 diabetes mellitus participants. T2DM: Type 2 diabetes mellitus.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Correlation of vitamin D with miRNA-200a and miRNA-200b in obese and obese with type 2 diabetes mellitus participants. A: MiRNA-200a; B: MiRNA-200b.
Figure 6
Open in New Tab Full Size Figure Download Figure
Figure 6 Prognostic importance of miRNA-200a and miRNA-200b in obese vs obese with type 2 diabetes mellitus participants. A: MiRNA-200a; B: MiRNA-200b.